Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

Protective strategies against perinatal brain injury represent a major challenge for modern neonatology. Erythropoietin (Epo) enhances endogenous mechanisms of repair and angiogenesis. In order to analyse the newest evidence on the role of Epo in prematurity, hypoxic ischemic encephalopathy (HIE) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrone, Serafina, Lembo, Chiara, Gironi, Federica, Petrolini, Chiara, Catalucci, Tiziana, Corbo, Giulia, Buonocore, Giuseppe, Gitto, Eloisa, Esposito, Susanna Maria Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031072/
https://www.ncbi.nlm.nih.gov/pubmed/35453337
http://dx.doi.org/10.3390/antiox11040652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031072/
https://www.ncbi.nlm.nih.gov/pubmed/35453337
http://dx.doi.org/10.3390/antiox11040652

Ejemplares similares